Shigeki Yamada
Datos Biográficos
| ID | 7954777 |
|---|---|
| NOMBRE | Shigeki Yamada |
| NOMBRES | Shigeki |
| APELLIDO | Yamada |
| FIRMA | YAMADA S |
| AFILIACIONES | Fujita Health University |
| ORCID | 0000-0002-3891-1323 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Associations of Community Pharmacists' Practices With Participation in Multidisciplinary Team Conferences in Japanese Home‐Based Care
Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder
We estimated that one in four Japanese patients with major depressive disorder who were prescribed first-time antidepressants had actionable drug-gene interactions. These results suggest that pre-emptive pharmacogenetic testing in the treatment of major depressive disorder could have important clinical implications
A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database
Increased suicidality after antiepileptic drug (AED) treatment remains controversial. This study aimed to investigate the occurrence of suicide-related events (SREs) in Japan. SREs signals with AEDs used orally were evaluated by calculating reporting odds ratios (RORs) and information components (ICs) using the Japanese Adverse Drug Event Report (JADER) database from April 2004 to December 2021. Additionally, factors affecting the occurrence of S…
Sin obras prominentes en esta página.
A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database
Increased suicidality after antiepileptic drug (AED) treatment remains controversial. This study aimed to investigate the occurrence of suicide-related events (SREs) in Japan. SREs signals with AEDs used orally were evaluated by calculating reporting odds ratios (RORs) and information components (ICs) using the Japanese Adverse Drug Event Report (JADER) database from April 2004 to December 2021. Additionally, factors affecting the occurrence of S…
Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder
We estimated that one in four Japanese patients with major depressive disorder who were prescribed first-time antidepressants had actionable drug-gene interactions. These results suggest that pre-emptive pharmacogenetic testing in the treatment of major depressive disorder could have important clinical implications
Associations of Community Pharmacists' Practices With Participation in Multidisciplinary Team Conferences in Japanese Home‐Based Care
Medical prescription (2 obras) · Medicine (2 obras) · Pharmacology (2 obras) · Psychiatry (2 obras) · Adverse drug event (1 obras) · Adverse effect (1 obras) · Antidepressant (1 obras) · Antiepileptic drug (1 obras) · Biology (1 obras) · Bipolar Disorder and Treatment (1 obras)